Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 6,971 across all filing types
Latest filing 2026-04-10 Foreign Filer Report
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-10 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS ‘Transaction notification’ under the UK’s Market Abuse Regulation providing detailed disclosures of share acquisitions by PDMRs (e.g., CEO, SVPs) following dividend reinvestment via the Company’s Share Reward Plan. This is a classic insider dealing/insider transactions notification. It matches the ‘Director’s Dealing’ category, which covers personal share transactions by company directors and executives.
2026-04-10 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-10 English
Transaction in Own Shares
Transaction in Own Shares Classification · 94% confidence The document is an official announcement of share repurchases by GSK plc, detailing the number of ordinary shares bought back under its existing buyback programme, transaction dates, prices, and venues. This aligns precisely with the “Transaction in Own Shares” category, which covers company reports of share repurchases or issuances. Therefore, the correct filing classification is POS.
2026-04-10 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-09 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS “Transaction notification” by a PDMR (President, US) detailing the acquisition of ADS, including ISIN, price, volume, date, and place. This corresponds to a director’s/insider share transaction report under MAR. Therefore it is classified as Director's Dealing (DIRS).
2026-04-09 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.